中国全科医学 ›› 2021, Vol. 24 ›› Issue (10): 1173-1178.DOI: 10.12114/j.issn.1007-9572.2021.00.177

• 专题研究 •    下一篇

全球自然感染SARS-CoV-2人群的抗体水平研究

李锦成,刘民*,刘珏*   

  1. 100191北京市,北京大学公共卫生学院
    *通信作者:刘民,教授;E-mail:liumin@bjmu.edu.cn 
    刘珏,副研究员;E-mail:jueliu@bjmu.edu.cn
  • 出版日期:2021-04-05 发布日期:2021-04-05
  • 基金资助:
    国家重点研发计划(2020YFC0846300;2020YFC0849500);国家自然科学基金重点项目(71934002)

Antibody Responses to SARS-CoV-2 in Naturally Infected Population Worldwide 

LI Jincheng,LIU Min*,LIU Jue*   

  1. School of Public Health,Peking University,Beijing 100191,China
    *Corresponding authors:LIU Min,Professor;E-mail:liumin@bjmu.edu.cn
    LIU Jue,Associate professor;E-mail:jueliu@bjmu.edu.cn
  • Published:2021-04-05 Online:2021-04-05

摘要: 新型冠状病毒肺炎(COVID-19)已蔓延至全球二百二十多个国家和地区,造成了全球大流行。通过SARS-CoV-2的特异性抗体的血清学检测可以估计人群感染的状况,有助于回顾性评估研究人群中疫情的规模或感染程度。本文对全球自然感染SARS-CoV-2一般人群和医务工作者、儿童、孕妇等特殊人群的血清抗体水平研究进行综述,以期更好地理解COVID-19流行期间人群的血清学特征和规律,对疾病的认识和后期疫情防控提供重要借鉴。综述发现全球范围内报告的自然感染SARS-CoV-2血清抗体阳性率在不同国家或地区有所不同,阳性率从低于0.1%到超过20%,其高低与不同血清学检测方法、检测时所处的疫情流行阶段有关。儿童的血清抗体阳性率低于其他年龄组,医务工作者、孕妇的血清抗体阳性率则与一般人群相似。未来有必要进一步持续监测血清抗体阳性水平,以评估COVID-19所致的疾病负担,为COVID-19疫情控制提供科学证据。

关键词: 新型冠状病毒肺炎, SARS-CoV-2, 自然感染, 血清抗体阳性率

Abstract: COVID-19 has spread to more than 220 countries and regions in the world,becoming a global pandemic. Serological testing of specific antibodies against SARS-CoV-2 can estimate the status of infection in the population,and help retrospectively assess the scale or degree of infection in the study population. This article reviews the SARS-CoV-2-specific antibody responses in naturally infected general population worldwide,and special populations such as medical workers,children,and pregnant women,aiming to provide important information for better understanding of SARS-CoV-2-specific serological features and patterns in populations in times of COVID-19,and for enhanced perception and containment of COVID-19. It has been found that the seroprevalence of SARS-CoV-2 antibodies reported globally for natural infections varies in different countries or regions,ranging from less than 0.1% to more than 20%,which may be associated with the differences in serological testing methods,and stages of COVID-19 pandemic during which the testing is performed. The seropositivity rate of children is lower than that of other age groups. But the seropositivity rate of medical workers or pregnant women is similar to that of the general population. To estimate the burden caused by COVID-19 and offer scientific evidence for the containment of the disease,it is essential to continuously carry out seroprevalence surveillance for SARS-CoV-2.

Key words: COVID-19, SARS-CoV-2, Natural infection, Seroprevalence of antibody